Ballance David James 4
4 · PhaseBio Pharmaceuticals Inc · Filed Dec 17, 2018
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Purchase
Common Stock
2018-12-13$3.94/sh+1,000$3,940→ 7,600 total
4 · PhaseBio Pharmaceuticals Inc · Filed Dec 17, 2018
Common Stock